Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Musculoskeletal | Rheumatology | Family Medicine
Disease Category: Lupus
Location: United States, GA
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus (SLE)
Patient Inclusion Criteria:
Patient Exclusion Criteria
CW ID: 175421
Date Last Changed:
July 22, 2013
Suzi DeFiesta, Research AdministratorCSI Research Inc11379 Southbridge Parkway Suite BAlpharetta, GA 30022Phone: 770-667-0220Fax: 770-667-0227
CSI Research Inc
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.